SCHEMBL8551090

SCHEMBL8551090

c1ccc(CC2COCC(c3cc(C4CCN(CCc5c[nH]c6ccccc56)CC4)n[nH]3)O2)cc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.48
DRD4 P21917 7/20 0.48
DRD3 P35462 5/20 0.48
HTR2A P28223 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
HTR1A P08908 2/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8545430 0.87 DRD4 (0.49) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL8917842 0.86 DRD2 (0.48) DRD2DRD4DRD3HTR1A
SCHEMBL8545455 0.70 DRD2 (0.50) DRD2DRD4DRD3HTR2AADRA2A
SCHEMBL11333398 0.69 DRD2 (0.76) DRD2DRD4DRD3HTR2AADRA2A
SCHEMBL8551091 0.69 HTR1A (0.53) DRD2HTR2AADRA2AADRA2BADRA2C
SCHEMBL6465788 0.68 HTR2A (0.88) DRD2DRD4DRD3HTR2AADRA2A
SCHEMBL8551088 0.67 HTR2A (0.42) DRD2DRD4DRD3HTR2AADRA2A
SCHEMBL13150441 0.66 HTR1A (0.79) DRD2DRD4DRD3HTR2AHTR1A
SCHEMBL11616710 0.66 HTR2A (0.62) DRD2DRD4DRD3HTR2AADRA2A
SCHEMBL24746503 0.66 HTR2A (0.74) DRD2DRD4DRD3HTR2AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0822814-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-12-09 EP claimed
EP-0822814-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-02-11 EP claimed
WO-1996032938-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-10-24 WO claimed
EP-0822814-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-12-09 EP disclosed
EP-0822814-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-02-11 EP disclosed
US-5668148-A BENIGN PROSTATIC HYPERTROPHY MERCK & CO., INC. (US) 1997-09-16 US disclosed
WO-1996032938-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-10-24 WO disclosed